Cargando…

A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer

BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhihua, Mei, Weijian, Song, Zhengbo, Jiao, Wenjie, Huang, Qinghua, Zhu, Lianxin, An, Chaolun, Shi, Jianguang, Wang, Wenxian, Yu, Guiping, Sun, Pingli, Zhang, Yinbin, Shen, Jianfei, Song, Yong, Gilbert, Sebastien, Ruetzler, Kurt, Villamizar, Nestor R., Xu, Chunwei, Qian, Jun, Yao, Wang, Yang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743510/
https://www.ncbi.nlm.nih.gov/pubmed/35070763
http://dx.doi.org/10.21037/tlcr-21-959
_version_ 1784629917282992128
author Zhu, Zhihua
Mei, Weijian
Song, Zhengbo
Jiao, Wenjie
Huang, Qinghua
Zhu, Lianxin
An, Chaolun
Shi, Jianguang
Wang, Wenxian
Yu, Guiping
Sun, Pingli
Zhang, Yinbin
Shen, Jianfei
Song, Yong
Gilbert, Sebastien
Ruetzler, Kurt
Villamizar, Nestor R.
Xu, Chunwei
Qian, Jun
Yao, Wang
Yang, Han
author_facet Zhu, Zhihua
Mei, Weijian
Song, Zhengbo
Jiao, Wenjie
Huang, Qinghua
Zhu, Lianxin
An, Chaolun
Shi, Jianguang
Wang, Wenxian
Yu, Guiping
Sun, Pingli
Zhang, Yinbin
Shen, Jianfei
Song, Yong
Gilbert, Sebastien
Ruetzler, Kurt
Villamizar, Nestor R.
Xu, Chunwei
Qian, Jun
Yao, Wang
Yang, Han
author_sort Zhu, Zhihua
collection PubMed
description BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1–3N0M0 NSCLC. METHODS: This study involved 3,002 patients with T1–3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model. RESULTS: Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001). CONCLUSIONS: The HI standard can improve both the prognosis and survival rates of patients with T1–3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases.
format Online
Article
Text
id pubmed-8743510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87435102022-01-21 A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer Zhu, Zhihua Mei, Weijian Song, Zhengbo Jiao, Wenjie Huang, Qinghua Zhu, Lianxin An, Chaolun Shi, Jianguang Wang, Wenxian Yu, Guiping Sun, Pingli Zhang, Yinbin Shen, Jianfei Song, Yong Gilbert, Sebastien Ruetzler, Kurt Villamizar, Nestor R. Xu, Chunwei Qian, Jun Yao, Wang Yang, Han Transl Lung Cancer Res Original Article BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1–3N0M0 NSCLC. METHODS: This study involved 3,002 patients with T1–3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model. RESULTS: Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001). CONCLUSIONS: The HI standard can improve both the prognosis and survival rates of patients with T1–3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases. AME Publishing Company 2021-12 /pmc/articles/PMC8743510/ /pubmed/35070763 http://dx.doi.org/10.21037/tlcr-21-959 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhu, Zhihua
Mei, Weijian
Song, Zhengbo
Jiao, Wenjie
Huang, Qinghua
Zhu, Lianxin
An, Chaolun
Shi, Jianguang
Wang, Wenxian
Yu, Guiping
Sun, Pingli
Zhang, Yinbin
Shen, Jianfei
Song, Yong
Gilbert, Sebastien
Ruetzler, Kurt
Villamizar, Nestor R.
Xu, Chunwei
Qian, Jun
Yao, Wang
Yang, Han
A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title_full A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title_fullStr A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title_full_unstemmed A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title_short A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
title_sort standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743510/
https://www.ncbi.nlm.nih.gov/pubmed/35070763
http://dx.doi.org/10.21037/tlcr-21-959
work_keys_str_mv AT zhuzhihua astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT meiweijian astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT songzhengbo astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT jiaowenjie astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT huangqinghua astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT zhulianxin astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT anchaolun astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT shijianguang astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT wangwenxian astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yuguiping astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT sunpingli astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT zhangyinbin astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT shenjianfei astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT songyong astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT gilbertsebastien astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT ruetzlerkurt astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT villamizarnestorr astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT xuchunwei astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT qianjun astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yaowang astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yanghan astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT zhuzhihua standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT meiweijian standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT songzhengbo standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT jiaowenjie standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT huangqinghua standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT zhulianxin standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT anchaolun standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT shijianguang standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT wangwenxian standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yuguiping standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT sunpingli standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT zhangyinbin standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT shenjianfei standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT songyong standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT gilbertsebastien standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT ruetzlerkurt standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT villamizarnestorr standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT xuchunwei standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT qianjun standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yaowang standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT yanghan standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer
AT standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer